Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a hu

Journal Article · · J. ImmunoTherapy Can.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; « less

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1901235
Journal Information:
J. ImmunoTherapy Can., Vol. 10, Issue (9)
Country of Publication:
United States
Language:
ENGLISH

References (36)

Therapeutic targeting of CD70 and CD27 journal March 2016
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy journal January 2018
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor journal May 1993
CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool journal October 2003
CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production journal January 2010
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo journal April 2007
CD27 Instructs CD4+ T Cells to Provide Help for the Memory CD8+ T Cell Response after Protein Immunization journal July 2008
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential journal July 2015
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness journal November 2017
Induction of CD70 on Dendritic Cells through CD40 or TLR Stimulation Contributes to the Development of CD8+T Cell Responses in the Absence of CD4+T Cells journal January 2005
The CD4+ T-cell help signal is transmitted from APC to CD8+ T-cells via CD27–CD70 interactions journal July 2012
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion journal October 2020
CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination journal May 2016
Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice journal March 2010
Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia journal July 2012
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering journal March 2022
Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab journal November 2016
Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells journal June 2017
Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex journal October 2021
Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography journal March 2017
CD28-mediated induction of proliferation in resting T cellsin vitro andin vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28 journal January 1997
Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models journal March 2022
O83 Phase 1 study of an anti-CD27 agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors
  • Shapira-Frommer, Ronnie; Dongen, Marloes GJ van; Dobrenkov, Konstantin
  • Journal for ImmunoTherapy of Cancer, Vol. 8, Issue Suppl 1 https://doi.org/10.1136/LBA2019.3
journal April 2020
Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex journal February 2003
Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice journal September 2013
Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology journal May 2009
Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation journal May 2005
Constitutive CD27/CD70 Interaction Induces Expansion of Effector-Type T Cells and Results in IFNγ-Mediated B Cell Depletion journal November 2001
Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions journal December 2002
Expression of Costimulatory Ligand CD70 on Steady-State Dendritic Cells Breaks CD8+ T Cell Tolerance and Permits Effective Immunity journal December 2008
Immune activation modulates hematopoiesis through interactions between CD27 and CD70 journal February 2005
CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy journal November 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment journal December 2017
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction journal April 2006
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy journal January 2020
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy journal June 2021

Similar Records

Related Subjects